X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3112) 3112
male (1717) 1717
index medicus (1649) 1649
female (1645) 1645
sputum - chemistry (1402) 1402
sputum (1319) 1319
adult (1286) 1286
middle aged (1158) 1158
respiratory system (973) 973
sputum - microbiology (741) 741
aged (708) 708
inflammation (680) 680
asthma (649) 649
adolescent (495) 495
induced sputum (484) 484
microbiology (481) 481
cystic fibrosis (477) 477
immunology (451) 451
diagnosis (442) 442
sputum - cytology (435) 435
biochemistry & molecular biology (399) 399
airway inflammation (388) 388
tuberculosis (381) 381
research (373) 373
animals (350) 350
research article (328) 328
infectious diseases (320) 320
child (317) 317
respiratory tract diseases (314) 314
analysis (309) 309
sensitivity and specificity (301) 301
sputum - metabolism (299) 299
young adult (294) 294
expression (286) 286
medicine (280) 280
biomarkers (279) 279
disease (266) 266
cell biology (254) 254
health aspects (254) 254
obstructive pulmonary-disease (245) 245
multidisciplinary sciences (244) 244
asthma - metabolism (243) 243
case-control studies (243) 243
allergy (240) 240
biomarkers - analysis (239) 239
chronic obstructive pulmonary disease (238) 238
asthma - physiopathology (220) 220
patients (216) 216
bronchoalveolar lavage fluid - chemistry (213) 213
proteins (212) 212
mycobacterium tuberculosis - isolation & purification (211) 211
identification (209) 209
bronchoalveolar lavage (208) 208
infections (207) 207
pharmacology & pharmacy (206) 206
bacteria (205) 205
care and treatment (204) 204
infection (204) 204
eosinophils (196) 196
asthma - immunology (194) 194
copd (194) 194
children (193) 193
polymerase chain reaction (193) 193
science (193) 193
cystic fibrosis - microbiology (190) 190
cystic fibrosis - metabolism (186) 186
lung diseases (186) 186
neutrophils (185) 185
forced expiratory volume (182) 182
respiratory function tests (179) 179
prospective studies (178) 178
enzyme-linked immunosorbent assay (174) 174
physiological aspects (173) 173
lung diseases, obstructive (171) 171
mucus (171) 171
lung (167) 167
critical care medicine (165) 165
cytokines (165) 165
asthma - diagnosis (164) 164
asthma - drug therapy (164) 164
lungs (164) 164
aged, 80 and over (161) 161
risk factors (160) 160
pseudomonas aeruginosa (157) 157
studies (156) 156
dna (155) 155
time factors (155) 155
molecular sequence data (154) 154
cystic-fibrosis (153) 153
treatment outcome (152) 152
tuberculosis, pulmonary - diagnosis (152) 152
administration, inhalation (151) 151
pulmonary tuberculosis (151) 151
asthma - pathology (149) 149
leukocyte count (149) 149
physiology (146) 146
pseudomonas-aeruginosa (146) 146
pulmonary disease, chronic obstructive - metabolism (146) 146
antibiotics (145) 145
reproducibility of results (145) 145
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3457) 3457
Chinese (43) 43
Japanese (35) 35
Polish (22) 22
German (21) 21
French (19) 19
Spanish (18) 18
Russian (15) 15
Turkish (5) 5
Italian (3) 3
Romanian (3) 3
Dutch (2) 2
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Hebrew (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of controlled release, ISSN 0168-3659, 2015, Volume 198, pp. 55 - 61
Inhaled antibiotics, such as tobramycin, for the treatment of Pseudomonas aeruginosa pulmonary infections are associated with the increase in life expectancy... 
Pseudomonas aeruginosa | Alginate | DNase | Tobramycin | Nanoparticle | Cystic fibrosis sputum | CHITOSAN/ALGINATE NANOPARTICLES | VIVO | DRUG-DELIVERY | SPUTUM | LUNG INFECTION | CHEMISTRY, MULTIDISCIPLINARY | BACTERIAL BIOFILMS | DEXTRAN SULFATE | IN-VITRO CHARACTERIZATION | GALLERIA-MELLONELLA | OCULAR DELIVERY | PHARMACOLOGY & PHARMACY | Recombinant Proteins - therapeutic use | Nanoparticles - chemistry | Humans | Pseudomonas aeruginosa - growth & development | Tobramycin - pharmacology | Deoxyribonuclease I - therapeutic use | Tobramycin - administration & dosage | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Deoxyribonuclease I - chemistry | Deoxyribonuclease I - pharmacology | Nanoparticles - therapeutic use | Anti-Bacterial Agents - chemistry | Adult | Tobramycin - chemistry | Glucuronic Acid - chemistry | Tobramycin - therapeutic use | Pseudomonas Infections - drug therapy | Recombinant Proteins - chemistry | Treatment Outcome | DNA - metabolism | Hexuronic Acids - chemistry | Pseudomonas aeruginosa - drug effects | Recombinant Proteins - pharmacology | Deoxyribonuclease I - administration & dosage | Chemistry, Pharmaceutical | Recombinant Proteins - administration & dosage | Sputum - metabolism | Chitosan - chemistry | Alginates - chemistry | Anti-Bacterial Agents - pharmacology | Nanoparticles - administration & dosage | Anti-Bacterial Agents - administration & dosage | Cystic Fibrosis - drug therapy | Dornase alfa | Analysis | Cystic fibrosis | Polymers | Health aspects | Index Medicus
Journal Article
Nature communications, ISSN 2041-1723, 2019, Volume 10, Issue 1, pp. 4927 - 8
Raman optical spectroscopy promises label-free bacterial detection, identification, and antibiotic susceptibility testing in a single step. However, achieving... 
RESISTANCE | INFECTION | MULTIDISCIPLINARY SCIENCES | CHILDREN | Neural Networks, Computer | Salmonella enterica - chemistry | Bacteria - chemistry | Proteus mirabilis - classification | Humans | Methicillin-Resistant Staphylococcus aureus - classification | Klebsiella - chemistry | Support Vector Machine | Streptococcus - chemistry | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Candida - classification | Streptococcus - classification | Bacterial Typing Techniques | Bacteria - classification | Klebsiella - classification | Single-Cell Analysis | Principal Component Analysis | Bacterial Infections - microbiology | Proteus mirabilis - chemistry | Bacterial Infections - drug therapy | Logistic Models | Spectrum Analysis, Raman - methods | Escherichia coli - chemistry | Methicillin-Resistant Staphylococcus aureus - chemistry | Deep Learning | Staphylococcus aureus - chemistry | Pseudomonas aeruginosa - chemistry | Candida - chemistry | Enterococcus - chemistry | Staphylococcus aureus - classification | Salmonella enterica - classification | Bacterial Infections - diagnosis | Pseudomonas aeruginosa - classification | Enterococcus - classification | Escherichia coli - classification | Urine | Raman spectra | Cell culture | Spectroscopy | Pathogens | Phenotypes | Clinical isolates | Identification | Drug resistance | Raman spectroscopy | Patients | Noise spectra | Deep learning | Methicillin | Antibiotics | Spectrum analysis | Machine learning | Sputum | Bacteria
Journal Article
Glycobiology, ISSN 0959-6658, 01/2015, Volume 25, Issue 1, pp. 88 - 100
Although mucin O-glycosylation of sputum from individuals suffering from cystic fibrosis (CF) is known to be altered relative to their unaffected counterparts,... 
paucimannose | sputum | bacterial colonization | N-glycans | N -glycans | cystic fibrosis | MUCUS GLYCOPROTEINS | CARBOHYDRATE DETERMINANTS | BIOCHEMISTRY & MOLECULAR BIOLOGY | STRUCTURAL-ANALYSIS | EPITHELIAL-CELL | AIRWAY DISEASE | ADHESION | MANNOSE-BINDING PROTEIN | PSEUDOMONAS-AERUGINOSA | MUCIN GLYCOSYLATION | O-GLYCANS | Aspergillus fumigatus - drug effects | Fucose - chemistry | Fucose - metabolism | Glycomics | Humans | Pseudomonas aeruginosa - growth & development | Cystic Fibrosis - pathology | Molecular Sequence Data | Male | Sialic Acids - chemistry | Acetylglucosamine - metabolism | Anti-Bacterial Agents - therapeutic use | Mannose - metabolism | Mucins - metabolism | Polysaccharides - chemistry | Adult | Female | Mannose - chemistry | Carbohydrate Sequence | Cystic Fibrosis - metabolism | Cystic Fibrosis - microbiology | Sialic Acids - metabolism | Glycosylation | Mucins - chemistry | Pseudomonas aeruginosa - drug effects | Salivary Proteins and Peptides - metabolism | Acetylglucosamine - chemistry | Aspergillus fumigatus - chemistry | Polysaccharides - metabolism | Staphylococcus aureus - chemistry | Host-Pathogen Interactions | Sputum - chemistry | Phenotype | Pseudomonas aeruginosa - chemistry | Adolescent | Aged | Aspergillus fumigatus - growth & development | Salivary Proteins and Peptides - chemistry | Carbohydrate Conformation | Staphylococcus aureus - drug effects | Staphylococcus aureus - growth & development | Cystic Fibrosis - drug therapy
Journal Article
Molecular Pharmaceutics, ISSN 1543-8384, 03/2016, Volume 13, Issue 3, pp. 863 - 872
Journal Article
Journal of controlled release, ISSN 0168-3659, 2014, Volume 178, Issue 1, pp. 8 - 17
Journal Article
Bioorganic & medicinal chemistry letters, ISSN 0960-894X, 2015, Volume 25, Issue 20, pp. 4370 - 4381
Journal Article
Journal Article
Journal Article